Critical reappraisal of short-acting bronchodilators for pediatric respiratory diseases

Abstract Short-acting bronchodilators are a class of medications commonly used to treat asthma, chronic obstructive pulmonary disease, and other respiratory conditions. The use of these medications has evolved over time as we have gained a better understanding of their effectiveness and safety in th...

Full description

Saved in:
Bibliographic Details
Main Authors: Amelia Licari (Author), Sara Manti (Author), Francesco Mastellone (Author), Michele Miraglia Del Giudice (Author), Gian Luigi Marseglia (Author), Maria Angela Tosca (Author), Asthma and Personalized Therapies Committee of the Italian Society of Pediatric Allergy & Immunology (SIAIP) (Author)
Format: Book
Published: BMC, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c6cf79ba72f48389a30a2c24b8815e8
042 |a dc 
100 1 0 |a Amelia Licari  |e author 
700 1 0 |a Sara Manti  |e author 
700 1 0 |a Francesco Mastellone  |e author 
700 1 0 |a Michele Miraglia Del Giudice  |e author 
700 1 0 |a Gian Luigi Marseglia  |e author 
700 1 0 |a Maria Angela Tosca  |e author 
700 1 0 |a Asthma and Personalized Therapies Committee of the Italian Society of Pediatric Allergy & Immunology   |q  (SIAIP)   |e author 
245 0 0 |a Critical reappraisal of short-acting bronchodilators for pediatric respiratory diseases 
260 |b BMC,   |c 2024-05-01T00:00:00Z. 
500 |a 10.1186/s13052-024-01675-0 
500 |a 1824-7288 
520 |a Abstract Short-acting bronchodilators are a class of medications commonly used to treat asthma, chronic obstructive pulmonary disease, and other respiratory conditions. The use of these medications has evolved over time as we have gained a better understanding of their effectiveness and safety in the pediatric population. This comprehensive review synthesizes the current understanding of short-acting β2-agonists and short-acting anticholinergics in children. It addresses indications, contraindications, safety considerations, and highlights areas where further research is needed to guide the most effective use of short-acting bronchodilators. 
546 |a EN 
690 |a Short-acting bronchodilators 
690 |a Children 
690 |a Bronchiolitis 
690 |a Wheezing 
690 |a Asthma 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Italian Journal of Pediatrics, Vol 50, Iss 1, Pp 1-12 (2024) 
787 0 |n https://doi.org/10.1186/s13052-024-01675-0 
787 0 |n https://doaj.org/toc/1824-7288 
856 4 1 |u https://doaj.org/article/8c6cf79ba72f48389a30a2c24b8815e8  |z Connect to this object online.